World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
70
Citations
20591
World Ranking
1914
National Ranking
810

Douglas T. Dieterich publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Douglas T. Dieterich sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 358 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Douglas T. Dieterich D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Douglas T. Dieterich sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 70 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Douglas T. Dieterich is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily spans the field of Medicine, with an emphasis on subfields including Epidemiology, Hepatology, Infectious Diseases, Surgery, and Cancer Research.

Their scholarly output includes extensive work on several main topics, such as Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, HIV/AIDS drug development and treatment, Pancreatitis Pathology and Treatment, and HIV/AIDS Research and Interventions.

The scientist's frequent collaborators include Paul Y. Kwo, Hie-Won Hann, Ho Bae, Tatyana Kushner, and Mark Sulkowski.

Douglas T. Dieterich has published extensively in peer-reviewed venues. The most frequent publication venues are:

  • Journal of Hepatology
  • Open Forum Infectious Diseases
  • Gastroenterology
  • Clinical Gastroenterology and Hepatology
  • JHEP Reports

Selected recent papers include:

  • Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis, 2020, Gastroenterology
  • Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma, 2020, Oncogene
  • Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer, 2021, Gut
  • Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update, 2021, Clinical Gastroenterology and Hepatology
  • Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection, 2022, Journal of Hepatology

Best Publications

  • Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.

    Francesca J. Torriani;Maribel Rodriguez-Torres;Jürgen K. Rockstroh;Eduardo Lissen

  • Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study

    Naga Chalasani;Herbert L. Bonkovsky;Robert Fontana;William Lee

  • A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update

    Emmet B. Keeffe;Douglas T. Dieterich;Steven Huy B. Han;Ira M. Jacobson

  • Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

    Susanna Naggie;Curtis Cooper;Michael Saag;Kimberly Workowski

  • A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: An Update

    Emmet B. Keeffe;Douglas T. Dieterich;Steven–Huy B. Han;Ira M. Jacobson

  • Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1

    David L. Wyles;Peter J. Ruane;Mark S. Sulkowski;Douglas Dieterich

  • A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.

    Emmet B. Keeffe;Douglas T. Dieterich;Steve Huy B. Han;Ira M. Jacobson

  • A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin

    Mark G. Swain;Ming–Yang Lai;Mitchell L. Shiffman;W. Graham E. Cooksley

  • Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.

    Emmet B. Keeffe;Stefan Zeuzem;Raymond S. Koff;Douglas T. Dieterich

  • Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.

    Nezam H. Afdhal;Douglas T. Dieterich;Paul J. Pockros;Eugene R. Schiff

  • Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.

    Vincent Soriano;Mark Sulkowski;Colm Bergin;Angelos Hatzakis

  • Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial

    Eric Lawitz;Jay P Lalezari;Tarek Hassanein;Kris V Kowdley

  • Anemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies

    Paul A. Volberding;Alexandra M. Levine;Douglas Dieterich;Donna Mildvan

  • Increasing burden of liver disease in patients with HIV infection

    Deepak Joshi;John O'Grady;Doug Dieterich;Brian Gazzard

  • Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection.

    Mark S. Sulkowski;Susanna Naggie;Jacob Lalezari;Walford Jeffrey Fessel

  • Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.

    Norbert Bräu;Norbert Bräu;Rena K. Fox;Peiying Xiao;Kristen Marks

  • American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.

    Siddharth Singh;Andrew J. Muir;Douglas T. Dieterich;Yngve T. Falck-Ytter

  • Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa.

    Douglas T Dieterich;Ronald Wasserman;Norbert Bräu;Norbert Bräu;Tarek I Hassanein

  • Care of patients with hepatitis C and HIV co-infection.

    Vincent Soriano;Massimo Puoti;Mark Sulkowski;Stefan Mauss

  • Drug-Induced Liver Injury Associated with the Use of Nonnucleoside Reverse-Transcriptase Inhibitors

    Douglas T. Dieterich;Patrick A. Robinson;James Love;Jerry O. Stern

  • Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial.

    Mark S Sulkowski;Kenneth E Sherman;Douglas T Dieterich;Mohammad Bsharat

Frequent Co-Authors

Mark S. Sulkowski
Mark S. Sulkowski Johns Hopkins University School of Medicine
Zobair M. Younossi
Zobair M. Younossi Inova Health System
Bruce R. Bacon
Bruce R. Bacon Saint Louis University
Kris V. Kowdley
Kris V. Kowdley Washington State University
Nezam H. Afdhal
Nezam H. Afdhal Beth Israel Deaconess Medical Center
Jürgen K. Rockstroh
Jürgen K. Rockstroh University Hospital Bonn
Ira M. Jacobson
Ira M. Jacobson New York University
Scott L. Friedman
Scott L. Friedman Icahn School of Medicine at Mount Sinai
Vincent Soriano
Vincent Soriano Universidad Internacional De La Rioja
Peter Ferenci
Peter Ferenci Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various allied health and science careers. For students seeking flexible learning options, exploring what medical degrees can I get online can help identify suitable programs that blend biology and healthcare, accessible from anywhere.

Public health is another complementary field, and many students consider pursuing a Master of Public Health (MPH) after microbiology. To find manageable entry points, it’s useful to know which online mph programs are easiest to get into, making it an attractive pathway for career advancement without stringent admission barriers.

Additionally, some graduates explore roles supporting children’s health and well-being, such as becoming a child life specialist. Understanding the certified child life specialist salary and certification requirements helps aspirants evaluate this rewarding profession.

Online degrees also increase accessibility for individuals with diverse backgrounds. For example, if you have a criminal record, knowing about the degrees for felons can guide you toward programs designed for fresh starts and career rebuilding.

Best Scientists Citing Douglas T. Dieterich

Trending Scientists

Recently Published Articles